Literature DB >> 16920966

Bone marrow stromal cell antigen 2 is a specific marker of type I IFN-producing cells in the naive mouse, but a promiscuous cell surface antigen following IFN stimulation.

Amanda L Blasius1, Emanuele Giurisato, Marina Cella, Robert D Schreiber, Andrey S Shaw, Marco Colonna.   

Abstract

Type I IFN-producing cells (IPC) are sentinels of viral infections. Identification and functional characterization of these cells have been difficult because of their small numbers in blood and tissues and their complex cell surface phenotype. To overcome this problem in mice, mAbs recognizing IPC-specific cell surface molecules have been generated. In this study, we report the identification of new Abs specific for mouse IPC, which recognize the bone marrow stromal cell Ag 2 (BST2). Interestingly, previously reported IPC-specific Abs 120G8 and plasmacytoid dendritic cell Ag-1 also recognize BST2. BST2 is predominantly specific for mouse IPC in naive mice, but is up-regulated on most cell types following stimulation with type I IFNs and IFN-gamma. The activation-induced promiscuous expression of BST2 described in this study has important implications for the use of anti-BST2 Abs in identification and depletion of IPC. Finally, we show that BST2 resides within an intracellular compartment corresponding to the Golgi apparatus, and may be involved in trafficking secreted cytokines in IPC.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16920966     DOI: 10.4049/jimmunol.177.5.3260

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  236 in total

1.  Determinants of tetherin antagonism in the transmembrane domain of the human immunodeficiency virus type 1 Vpu protein.

Authors:  Raphaël Vigan; Stuart J D Neil
Journal:  J Virol       Date:  2010-10-06       Impact factor: 5.103

2.  Tetherin has negligible activity in restricting hepatitis C virus in hepatocytes.

Authors:  Li Ye; Xu Wang; Jieliang Li; Jinping Liu; Servio H Ramirez; Jianguo Wu; Wenzhe Ho
Journal:  Innate Immun       Date:  2011-09-22       Impact factor: 2.680

3.  Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses.

Authors:  Daniela Giordano; Chang Li; Mehul S Suthar; Kevin E Draves; Daphne Y Ma; Michael Gale; Edward A Clark
Journal:  J Leukoc Biol       Date:  2010-12-22       Impact factor: 4.962

4.  Dendritic cells regulate natural killer cell activation and epithelial injury in experimental biliary atresia.

Authors:  Vijay Saxena; Pranavkumar Shivakumar; Gregg Sabla; Reena Mourya; Claire Chougnet; Jorge A Bezerra
Journal:  Sci Transl Med       Date:  2011-09-28       Impact factor: 17.956

5.  Virus-activated interferon regulatory factor 7 upregulates expression of the interferon-regulated BST2 gene independently of interferon signaling.

Authors:  Mariana G Bego; Johanne Mercier; Eric A Cohen
Journal:  J Virol       Date:  2012-02-01       Impact factor: 5.103

6.  Spontaneous autoimmunity in the absence of IL-2 is driven by uncontrolled dendritic cells.

Authors:  Sara H Isakson; Shoshana D Katzman; Katrina K Hoyer
Journal:  J Immunol       Date:  2012-07-09       Impact factor: 5.422

7.  Assessing the development of murine plasmacytoid dendritic cells in Peyer's patches using adoptive transfer of hematopoietic progenitors.

Authors:  Haiyan S Li; Stephanie S Watowich
Journal:  J Vis Exp       Date:  2014-03-17       Impact factor: 1.355

8.  Bst2/Tetherin Is Induced in Neurons by Type I Interferon and Viral Infection but Is Dispensable for Protection against Neurotropic Viral Challenge.

Authors:  Alicia M Holmgren; Katelyn D Miller; Sarah E Cavanaugh; Glenn F Rall
Journal:  J Virol       Date:  2015-08-26       Impact factor: 5.103

9.  In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells.

Authors:  Marianna Ioannou; Themis Alissafi; Louis Boon; Dimitrios Boumpas; Panayotis Verginis
Journal:  J Immunol       Date:  2013-02-04       Impact factor: 5.422

Review 10.  Tetherin/BST-2: Restriction Factor or Immunomodulator?

Authors:  Sam X Li; Bradley S Barrett; Kejun Guo; Mario L Santiago
Journal:  Curr HIV Res       Date:  2016       Impact factor: 1.581

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.